Berberine: A Rising Star in the Management of Type 2 Diabetes—Novel Insights into Its Anti-Inflammatory, Metabolic, and Epigenetic Mechanisms
Da Liu, Liting Zhao, Ying Wang, Lei Wang, Donglu Wu, Yangyang Liu, Michael Danilenko, Maira Huerta-Reyes, Gil Alfonso Magos-Guerrero, Oscar Barrera-Vázquez · 2025
Read Berberine: A Rising Star in the Management of Type 2 Diabetes—Novel Insights into Its Anti-Inflammatory, Metabolic, and Epigenetic Mechanisms by Da Liu, Liting Zhao, Ying Wang, Lei Wang, Donglu Wu, Yangyang Liu, Michael Danilenko, Maira Huerta-Reyes, Gil Alfonso Magos-Guerrero, Oscar Barrera-Vázquez (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-12735998.txt.
Description
Da Liu and co-authors review in 2025 berberine, a plant compound, as a help for type two diabetes. The disease pairs weak insulin response with worn insulin making cells. It is a large and growing health load in the world.
The review pulls work from two big data bases on how the compound acts. It lifts insulin response, steers sugar make and move, and calms swelling and rust like cell harm. It also touches gene switch enzymes and joined drug plans. Ills of the kidney, eye, heart, and nerves tied to diabetes get their own pass in the review.
Catalog record
| CREATOR | Da Liu, Liting Zhao, Ying Wang, Lei Wang, Donglu Wu, Yangyang Liu, Michael Danilenko, Maira Huerta-Reyes, Gil Alfonso Magos-Guerrero, Oscar Barrera-Vázquez |
|---|---|
| YEAR | 2025 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 55 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |